The startup develops healthcare technology that enhances data liquidity and security while realigning healthcare systems to focus on chronic care management. By facilitating value-based payment services, the company aims to improve health outcomes across various metrics, including infant mortality and life expectancy, for healthcare providers and enterprises.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare systems face challenges in achieving data liquidity and security, hindering their ability to effectively manage chronic care and implement value-based payment models. This results in suboptimal health outcomes across key metrics, including infant mortality and life expectancy.
Solution
Health2047 operates as a venture studio that builds and invests in early-stage companies focused on transforming healthcare. The company focuses on ventures that drive meaningful impact on health equity and value, emphasizing affordable care, equitable delivery, and improved outcomes. Health2047 provides strategic and operational support, from initial setup to funding, leveraging the American Medical Association's expertise and network. The company's approach includes founder support, active network engagement, and access to functional and industry-specific resources.
Target Audience
Health2047 targets healthcare entrepreneurs and early-stage companies seeking to transform healthcare through innovative solutions, as well as investors looking for opportunities in the healthcare sector.
Features
- Focus on data, chronic disease, and productivity to drive better care and reduce costs.
- Venture studio model providing seed funding and access to a network of co-investors and corporate partners.
- Physician- and patient-centric insights from the American Medical Association.
- Opportunities to pilot and test solutions through a network of partners.
- Mentorship from physicians, executives, and venture capitalists.
- Shared infrastructure resources for HIPAA compliance and HR policies.
- Support for crafting business cases for venture capital firms and strategic corporate investors.